Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. carcinoma tumor
Show results for
Products

Companies

News
Articles

Refine by
Date

  • Older

Carcinoma Tumor Articles & Analysis

7 news found

Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients

Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients

This prospective, single-arm multicenter study demonstrated that Embrace HES effectively embolized malignant and benign hypervascular tumors by blocking tumor blood supply with technical success and persistent embolization,[i] as noted in imaging follow-up at 30-days, in all eight patients treated on this study. ...

ByInstylla, Inc.


Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at AACR Annual Meeting

Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at AACR Annual Meeting

Specifically, the authors outline the benefits of calibrated release gene circuit technology, which combines the advantages of secreted and membrane-tethered cytokine-mediated stimulation of the patient’s immune system, to better control solid tumors. This technology is being applied in the design of multiple Senti Bio pipeline products including SENTI-301 and SENTI-401, ...

BySenti Biosciences


Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium

Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium

The test integrates genomic and epigenomic signatures to detect disease without the need for tumor tissue. (Abstract 168) Additionally, clinical utility data will demonstrate that the Guardant360® liquid biopsy test detects microsatellite instability-high (MSI-H) status in patients with advanced gastrointestinal cancers at a similar frequency to tissue-based testing1,2. ...

ByGuardant Health, Inc.


Icecure Medical announces new independent data published in the journal of cancer therapy showing that percutaneous Cryoablation presents a potential substitute for lumpectomy for tumors <15mm using Prosense

Icecure Medical announces new independent data published in the journal of cancer therapy showing that percutaneous Cryoablation presents a potential substitute for lumpectomy for tumors <15mm using Prosense

Marianna University Breast & Imaging Center, Kawasaki City, Japan enrolled eight female patients, 53 – 72 years-old mean age 62 years, diagnosed with invasive ductal carcinoma (IDC) tumors. Percutaneous ultrasound-guided cryoablation of the breast tumor was performed using IceCure’s ProSense, under local anesthesia without the ...

ByIceCure Medical Ltd


Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit

Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit

“We reported a complete response in one patient, and tumor reductions with stable disease that has lasted more than 16 weeks in two patients as well as disease control in most patients at the target dose. ...

ByAdaptimmune LLC


Pioneering VeraForm® in Head and Neck Cancer Treatment: Sarcomatoid Carcinoma Tumor Bed Marking

Pioneering VeraForm® in Head and Neck Cancer Treatment: Sarcomatoid Carcinoma Tumor Bed Marking

However, given the surgical site often lies in soft tissue, exact identification of the native tumor bed can present some difficulty for radiation planning. The surgical and radiation oncology team at Providence Mission Hospital (Mission Viejo, Ca) elected to use a novel tumor bed marker called VeraForm for a sarcomatoid carcinoma. ...

ByVidera Surgical Inc.


Application of Whole-Genome Sequencing in Older Esophageal Carcinoma FFPE Tissues Reveals Novel Insights

Application of Whole-Genome Sequencing in Older Esophageal Carcinoma FFPE Tissues Reveals Novel Insights

Collection of fresh-frozen tumor samples is often challenging or infeasible, leading many studies to rely on formalin-fixed, paraffin-embedded (FFPE) tumor tissue samples. ...

ByGenuity Science

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT